Index of reports
> Death (786)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 786 Next >>
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male, weighing 77.2 kg (169.8 pounds)
Reactions: Sepsis, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
CC-4047
Dosage: 4 milligram
Administration route: Oral
Start date: 2012-05-04
End date: 2012-05-08
CC-4047
Dosage: 4 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
End date: 2012-04-16
CC-4047
Dosage: 2 milligram
Administration route: Oral
Start date: 2012-05-08
CC-4047
Dosage: 2 milligram
Administration route: Oral
Start date: 2012-04-27
Clarithromycin
Dosage: 1000 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
Dexamethasone
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
Revlimid
Dosage: 5 milligram
Administration route: Oral
Other drugs received by patient: Atenolol; Hydrocortisone; Omega-3 Fatty Acids; Potassium Chloride; Atorvastatin Calcium; Metformin HCL; Amlodipine; Vasotec; Glyburide; Zometa; Prilosec; Magnesium Oxide; Niaspan; Tylenol; Actos; Imodium; Valtrex; Aspirin; Darbepoetin Alfa-Polysorbate; Feosol; Hydrocortisone
Possible Dexamethasone side effects in female
Reported by a physician from Bulgaria on 2012-08-24
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Circulatory Collapse, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-25
Dexamethasone
Dosage: 40 milligram
Start date: 2012-06-02
End date: 2012-06-05
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-26
Dexamethasone
Dosage: 20 milligram
Start date: 2012-05-16
End date: 2012-05-19
Doxorubicin Hydrochloride
Dosage: 80 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-26
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-30
End date: 2012-06-07
Vincristine
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-06-02
Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Dexamethasone side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Dexamethasone side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death, Chalazion
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-08-13
End date: 2012-01-03
Other drugs received by patient: Bisphosphonates; Travoprost
Possible Dexamethasone side effects in 59 year old female
Reported by a physician from United States on 2012-08-22
Patient: 59 year old female, weighing 67.8 kg (149.1 pounds)
Reactions: Embolism, Muscular Weakness, Gastric Haemorrhage, Cardiac Arrest
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Amyloidosis
Start date: 2012-07-09
End date: 2012-08-09
Melphalan Hydrochloride
Dosage: 0.22 mg/kg, cyclic
Administration route: Oral
Indication: Amyloidosis
Start date: 2012-07-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Amyloidosis
Start date: 2012-07-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Possible Dexamethasone side effects in 82 year old male
Reported by a consumer/non-health professional from United Kingdom on 2012-08-22
Patient: 82 year old male
Reactions: Flushing, Malaise, Feeling Hot, Chills, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 70 mg/m2, qd
Start date: 2011-08-09
Bendamustine Hydrochloride
Dosage: 70 mg/m2, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-13
End date: 2011-06-14
Bendamustine Hydrochloride
Dosage: 70 mg/m2, qd
Start date: 2011-07-11
Dexamethasone
Dosage: 20 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-02
Other drugs received by patient: Ciprofloxacin HCL; Prilosec; Fluconazole; Acyclovir; Ramipril; Omeprazole; Allopurinol Sodium; Enoxaparin Sodium; Simvastatin; Aspirin
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Soft Tissue Neoplasm
Trabectedin
Dosage: 1500 microgram per sq meter, q3w
Indication: Soft Tissue Neoplasm
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-22
Patient:
Reactions: Lung Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 180 mg, qd
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-05-30
Dexamethasone
Dosage: 40 mg, unk
Indication: Mantle Cell Lymphoma
Mabthera
Dosage: 750 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-05-29
Velcade
Dosage: 2.6 mg, qd
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-06-08
Other drugs received by patient: Rocephin; Glucophage; Fasturtec; Lasix; Duphalac; Colchicine; Actrapid / 00030501 /; Xanax; Ventolin; Albumin; Atarax; Nexium; Zelitrex / 01269701 /; Tranxene; Bactrim; Imovane; Magnesium Sulfate; Ramipril; Citalopram Hydrobromide; Folic Acid; Oxazepam; Pentoxifylline; Lasix
Possible Dexamethasone side effects in 45 year old female
Reported by a physician from United States on 2012-08-21
Patient: 45 year old female
Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-06-01
Cisplatin
Dosage: unk
Indication: Mycosis Fungoides
Cyclophosphamide
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Daunorubicin HCL
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Dexamethasone
Dosage: unk
Indication: Mycosis Fungoides
Etoposide
Dosage: unk
Indication: Mycosis Fungoides
Fludara
Dosage: 2 cycles
Indication: Mycosis Fungoides
Ifosfamide
Dosage: unk
Indication: Mycosis Fungoides
Prednisone
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Vincristine
Dosage: unk
Indication: Mycosis Fungoides
Start date: 2006-01-01
Possible Dexamethasone side effects in 77 year old male
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-21
Patient: 77 year old male
Reactions: Adverse Drug Reaction, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Dosage: in cycle 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Dosage: in cycle 1
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: on days 1 to 5
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Possible Dexamethasone side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-21
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from Germany on 2012-08-20
Patient:
Reactions: Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: unk
Indication: Multiple Myeloma
Start date: 2012-03-26
End date: 2012-07-05
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2012-03-26
End date: 2012-07-05
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2012-03-26
End date: 2012-07-05
Other drugs received by patient: Zometa; Amoxicillin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: female
Reactions: Hyperglycaemia, Malnutrition, Fall, Hepatic Enzyme Increased, Neoplasm Malignant, Oral Candidiasis, Oedema Peripheral, Urosepsis, Pulmonary Oedema, Asthenia, Acute Respiratory Failure, Escherichia Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 4 mg, bid
Indication: Metastases To Central Nervous System
Start date: 2012-05-02
Dexamethasone
Dosage: unk
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2012-05-31
Other drugs received by patient: Folic Acid; Provera; Duragesic-100; Celexa; Clarinex / 01202601 /; Estrace; Flexeril; Xanax; Fluticasone Propionate; Pepcid; Vicodin; Keppra; Compazine
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-17
Patient:
Reactions: Off Label Use, Hypoxia, Pleural Effusion, Bacterial Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: (pegylated) 2500 units/ m2/ dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: on days 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 and as cns involvement on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: divided into 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: on day 15 and triple therapy on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: by push day 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-17
Patient:
Reactions: Vomiting, Cardio-Respiratory Arrest, International Normalised Ratio Increased, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-07-03
End date: 2012-07-14
Velcade
Dosage: 1.3 mg, unk
Indication: Multiple Myeloma
Start date: 2012-07-03
End date: 2012-07-13
Other drugs received by patient: Carvedilol; Omeprazole; Calcium; Acenocoumarol; Candesartan Cilexetil; Prednisone TAB; Furosemide; Folic Acid; Movicol / 01053601 /
Possible Dexamethasone side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 68 year old female, weighing 88.0 kg (193.6 pounds)
Reactions: Dyspnoea, Pneumonia, Urinary Tract Infection, Constipation, Disease Progression, Multi-Organ Failure, Hypothyroidism, Gastrooesophageal Reflux Disease, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Crizotinib
Dosage: 500 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-26
End date: 2011-08-16
Dexamethasone
Dosage: 8 mg
Administration route: Oral
Indication: Palliative Care
Start date: 2011-07-05
Other drugs received by patient: Calcium; Vicoprofen; Levothyroxine Sodium; Prochlorperazine; Omeprazole; Albuterol; Oxycontin; Ondansetron; Lactulose; Folic Acid; Atorvastatin; Colace; Clonazepam
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-16
Patient:
Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: male, weighing 82.4 kg (181.3 pounds)
Reactions: Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Carfilzomib
Dosage: 38 milligram
Indication: Multiple Myeloma
Start date: 2011-08-15
Carfilzomib
Start date: 2012-04-23
End date: 2012-07-30
Carfilzomib
Start date: 2011-08-22
Carfilzomib
Start date: 2011-12-05
Carfilzomib
Start date: 2012-02-27
Carfilzomib
Start date: 2011-09-12
Carfilzomib
Start date: 2012-01-03
Dexamethasone
Start date: 2012-04-02
End date: 2012-06-11
Dexamethasone
Start date: 2011-12-05
Dexamethasone
Start date: 2012-03-26
Dexamethasone
Indication: Multiple Myeloma
Start date: 2011-08-15
Dexamethasone
Start date: 2011-11-28
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-15
End date: 2012-07-09
Other drugs received by patient: Vicodin; Warfarin Sodium; Warfarin Sodium; Carvedilol; Lasix; Zometa; Carvedilol; Potassium Chloride; Compazine; Lasix; Valacyclovir Hydrochloride; Calcium; Metformin Hydrochloride; Omeprazole
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-08-15
Patient:
Reactions: Off Label Use, Lung Disorder, Cerebral Infarction, Cardiac Failure, Shock Haemorrhagic, Myocardial Haemorrhage, Duodenal Ulcer Haemorrhage, Ventricular Fibrillation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Indication: Leukaemia Plasmacytic
Start date: 2012-04-17
End date: 2012-05-13
Velcade
Dosage: 1.3 mg, unk
Indication: Leukaemia Plasmacytic
Start date: 2012-04-20
End date: 2012-04-30
Other drugs received by patient: Lactulose; Rebamipide
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Page 1 Next >>
|